Počet záznamů: 1
Evaluation of 177Lu-nimotuzumab for Targeted Radioimmunotherapy of EGFR Expressing Tumors
- 1.Beckford, D. R., Balogh, L., Postenyi, Z., Mathe, D., Eigner, S., Eigner-Henke, K., Montana, R. L., Melichar, F. Evaluation of 177Lu-nimotuzumab for Targeted Radioimmunotherapy of EGFR Expressing Tumors. European Journal of Nuclear Medicine and Molecular Imaging. 2012, 39(P0089), S327-S327. ISSN 1619-7070. E-ISSN 1619-7089.
Počet záznamů: 1